Practical and Theoretical Radiotherapy Physics Courses
Course overview
This course provides practical and theoretical education for the support of a modern radiotherapy physics service within radiotherapy.
It is aimed primarily at recently qualified radiotherapy physicists, but should also be invaluable to post-graduate students, researchers, clinical oncologists, engineers, radiographers, manufacturers’ representatives and in fact, anyone needing to deepen or update their understanding of this rapidly evolving field.
The faculty is composed of physicists, clinicians and radiographers, many of whom are internationally renowned for their expertise. Workshops and demonstrations make full use of the facilities of the Radiotherapy and Physics Departments of The Royal Marsden NHS Foundation Trust. The course content is reviewed annually to reflect changes in practice and technology.
Course details
4-8 November 2025: the course in November will be held at our Sutton Site
Course fees
The cost for one week is £800.00. For those wishing to book the complete two weeks, the cost is discounted to £1,350.
External, full-time PhD students with proof of academic registration can book the eight lecture days of both weeks for a total of £700.
For registration details you can email our course secretary.
Contacts
Further details on course content can be obtained from the course organisers:
Tel: +44 (0)20 7808 2506
Fax: +44 (0)20 7808 2522
Tel: +44 (0)20 8661 3475
Fax: +44 (0)20 8643 3812
Latest ICR News
Scientists discover how to remove skin cancer’s protective armour and stop it spreading
Scientists have uncovered a protein that acts like a ‘suit of armour’ for cancer cells, shielding them from hostile environments and allowing one of the deadliest forms of skin cancer to spread through the body.
-is-malignancy-of-the-esophagus-cancer-of-the-esophagus-ct-with-contrast.jpg?sfvrsn=70ef5f67_1 "Esophageal cancer (or oesophageal cancer) is malignancy of the esophagus. Cancer of the esophagus, CT with contrast.")
New study reveals how oesophageal cancer adapts to treatment
Researchers have tracked how the most common form of oesophageal cancer and its immune environment change during a standard form of treatment – offering vital clues that could shape future therapies, so they work for longer.
Newly discovered role of enzyme could explain link between diabetes and cancer
Cell biologists have made a significant advance, uncovering the key role of an enzyme in determining the physical structure and behaviour of cancer cells, including how they spread.
ICR researcher awarded prestigious lectureship for practice-changing breast cancer research
Dr Maggie Cheang, a breast cancer researcher at The Institute of Cancer Research, London, has been awarded the prestigious CL Oakley lectureship.